Shanrong Biotechnology Corp.
SRBT
$0.3216
-$0.3284-50.52%
| 12/31/2009 | 09/30/2009 | 06/30/2009 | 03/31/2009 | 12/31/2008 | |
|---|---|---|---|---|---|
| Revenue | 91.31% | 126.90% | 99.96% | 46.08% | -11.04% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 91.31% | 126.90% | 99.96% | 46.08% | -11.04% |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 91.31% | 126.90% | 99.96% | 46.08% | -11.04% |
| SG&A Expenses | 98.08% | 5.39% | 14.80% | 8.47% | 15.17% |
| Depreciation & Amortization | 224.72% | 224.72% | 0.00% | 0.00% | 0.00% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 99.52% | 7.99% | 14.65% | 8.39% | 14.97% |
| Operating Income | -101.88% | 24.71% | 8.95% | 2.19% | -25.46% |
| Income Before Tax | -86.70% | 19.74% | 3.44% | -3.78% | -33.37% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -86.70% | 19.74% | 3.44% | -3.78% | -33.37% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -86.70% | 19.74% | 3.44% | -3.78% | -33.37% |
| EBIT | -101.88% | 24.71% | 8.95% | 2.19% | -25.46% |
| EBITDA | -103.40% | 25.09% | 9.08% | 2.23% | -25.93% |
| EPS Basic | 7.22% | 76.39% | -1.34% | -86.49% | -89.56% |
| Normalized Basic EPS | 7.22% | 76.39% | -1.34% | -86.49% | -89.56% |
| EPS Diluted | 6.34% | 75.62% | -2.46% | -88.00% | -91.09% |
| Normalized Diluted EPS | 7.22% | 76.39% | -1.34% | -86.49% | -89.56% |
| Average Basic Shares Outstanding | -14.90% | 122.38% | 37.96% | 18.69% | 47.24% |
| Average Diluted Shares Outstanding | -14.90% | 122.38% | 37.96% | 18.69% | 47.24% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
